Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 030774/0860 | |
| Pages: | 3 |
| | Recorded: | 07/09/2013 | | |
Attorney Dkt #: | 09548.1131WO,09548.1131D1 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
2
|
|
Patent #:
|
|
Issue Dt:
|
07/24/2012
|
Application #:
|
12090037
|
Filing Dt:
|
08/27/2008
|
Publication #:
|
|
Pub Dt:
|
07/09/2009
| | | | |
Title:
|
METHOD OF PREVENTING ACUTE OR SUB-ACUTE HEPATIC FAILURE IN A SUBJECT BY ADMINISTERING A SOLUBLE HUMAN TUMOR NECROSIS FACTOR ALPHA FUSION PROTEIN
|
|
|
Patent #:
|
|
Issue Dt:
|
11/05/2013
|
Application #:
|
13529402
|
Filing Dt:
|
06/21/2012
|
Publication #:
|
|
Pub Dt:
|
11/22/2012
| | | | |
Title:
|
METHOD OF PREVENTING ACUTE OR SUB-ACUTE HEPATIC FAILURE BY ADMINISTERING A LONG-ACTING RECOMBINANT HUMAN SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR II FUSION PROTEIN
|
|
Assignee
|
|
|
BIN YANG ROAD, LANE 50, NO. 2, ROOM 203. |
SHANGHAI, CHINA |
|
Correspondence name and address
|
|
HAMRE, SCHUMANN, MUELLER & LARSON, P.C.
|
|
P.O. BOX 2902
|
|
MINNEAPOLIS, MN 55402
|
Search Results as of:
05/11/2024 12:23 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|